Z.ai raised $5 billion for the second time in two months. Its stock has fallen 73% since June, and Washington just named it in a federal distillation warning

Z.ai priced a combined $5 billion financing this week -- roughly $2 billion from a discounted share placement, $3 billion from zero-coupon convertible bonds -- its second major raise in two months, after a roughly $4 billion share placement in July, and, by outside reporters' count, close to $9.6 billion total since its Hong Kong listing. The timing is what makes it a story rather than a routine funding update: the round priced eight days after the NSA, CISA and FBI publicly named Z.ai as one of six Chinese firms accused of extracting billions of tokens from Claude, GPT, Gemini and Grok to shortcut its own model development.

The mechanics of the raise are two different bets on the same stock. The share tranche sold 21.97 million new H-shares at HK$714 apiece -- a 9.96% discount to Friday's HK$793 close -- raising roughly $2 billion outright and diluting existing holders immediately. The bond tranche is the more interesting instrument: RMB 20.14 billion (about $3 billion) in zero-coupon notes due September 2027, convertible at HK$892.50 a share, a 25% premium over the placement price. Buyers of the bonds get no interest and are, in effect, betting the stock recovers well above even Friday's level within a year -- otherwise they simply get their principal back.

The stock chart underneath the raise is the part the financing headlines skip. Z.ai's Hong Kong-listed shares hit an intraday peak of HK$2,980 on June 22; by the Thursday before this week's announcement they'd fallen to HK$793 -- a decline of roughly 73% -- and this week's placement price of HK$714 is lower still. A company can raise $5 billion twice in two months and still be selling shares for a quarter of what they were worth ten weeks earlier. That's not necessarily a sign anything is wrong with the business -- richly valued AI stocks across the board have given back 2026 gains -- but it does mean the "dilution" conversation around this raise is happening against a stock that was already down heavily before the new shares showed up.

(A zero-coupon convertible bond is a loan that pays no interest -- the lender's entire return comes from either converting into stock at a set price or getting the original principal back at maturity. Pricing one at a 25% premium to a stock that just fell 73% is a wager that the worst of the decline is over.)

What the money buys is not in dispute. Z.ai says roughly 60% of the combined proceeds go to its next-generation GLM foundation models -- research, large-scale training, a "fully self-training system", production inference and computing infrastructure -- plus automated training-data generation, long-range reasoning work, and what the company calls domestic-chip adaptation: retooling its training and inference stack to run on Chinese-made accelerators rather than the Nvidia hardware US export controls increasingly restrict. That last line item is the one the distillation advisory makes newly relevant.

The September 8 advisory, AA26-251A, doesn't single out Z.ai -- it names DeepSeek, Alibaba, Moonshot AI, MiniMax, StepFun and Z.ai as a group, and alleges they routed distillation requests through fraudulent accounts, third-party API aggregators, and gray-market "transfer stations" designed to strip identifying metadata and evade US labs' geographic and rate limits. The agencies say the campaigns extracted billions of tokens across millions of exchanges from Claude, GPT, Gemini and Grok since at least late 2024, likely with the Chinese government's knowledge. Z.ai has not issued a public response to the advisory as of this reporting.

There's a real business under the financing noise, which is part of why investors kept showing up. Z.ai's first-half 2026 revenue reached 954 million yuan, a 399.7% jump from a year earlier, with API revenue from corporate clients rising more than 27-fold. That's the number that makes the raise legible as growth capital rather than a rescue -- a company scaling revenue that fast plausibly does need $5 billion for training runs and inference capacity. It doesn't resolve whether some of what it's scaling was trained on distilled outputs from US models, which is a question about the last two years, not the next two quarters.

None of this settles the underlying dispute the advisory raised -- whether Z.ai's models genuinely rest on distilled American training data, or how much. What it does settle is a narrower question: that accusation, at least so far, has cost Z.ai nothing in the market that actually funds it. Whichever number -- the funding total or the distillation claim -- turns out to matter more to Z.ai's next year is still an open question, and it's one the company's own revenue growth is buying it time to avoid answering.

A stock down 73% found buyers for $5 billion in new paper eight days after a joint US intelligence and law-enforcement advisory put its name on a list of six.